Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-924 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-16 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34 |
filingDate |
1999-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_778781d379ace42607eac89026e0d754 |
publicationDate |
1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5998132-A |
titleOfInvention |
Method and apparatus for detecting cancer, influenza, or HIV based on α-N-acetyl-galactosaminidase detection |
abstract |
HIV- and influenza virus-infected cells secrete alpha -N-acetylgalactosaminidase into the blood stream. Secretion of alpha -N-acetylgalactosaminidase is also associated with cancer. Elevated levels of alpha -N-acetylgalactosaminidase in the blood stream result in the deglycosylation of the Gc protein. This inactivates the MAF precursor activity of the Gc protein, leading to immunosuppression. Thus, the alpha -N-acetylgalactosaminidase activity in a patient's bloodstream can serve as a diagnostic and prognostic index. Antibody-sandwich ELISA methods and kits for alpha -N-acetylgalactosaminidase as an antigen were developed to detect serum or plasma alpha -N-acetylgalactosaminidase activity in patients and are used as a diagnostic/prognostic index. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3187585-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2679596-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2848937-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3072901-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3069730-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2586461-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012170765-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2568289-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2873423-A2 |
priorityDate |
1996-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |